WRR-99

WRR‑99 is an experimental small molecule inhibitor designed to target the cysteine protease cruzipain, also known as cruzain, which is a key enzyme in the parasite Trypanosoma cruzi. This enzyme plays a crucial role in the life cycle and pathogenicity of T. cruzi, the causative agent of Chagas disease. Structural studies have shown that WRR‑99 binds covalently to cruzipain, acting as a hydrolase inhibitor and potentially blocking parasite development[2][3][8]. The compound has been studied primarily for its potential application in antiparasitic drug design.

Other names

(3S)-3-hydroxy-3-{[(1R)-1-[(3-methylbutyl)carbamoyl]-3-phenylpropyl]carbamoyl}propanoic acid(3S)-3-hydroxy-3-(((1R)-1-((3-methylbutyl)carbamoyl)-3-phenylpropyl)carbamoyl)propanoic acid(3S)-3-hydroxy-4-{(2R)-1-[ (3-methylbutyl)amino ] -1 -oxo -4 -phenylbutan -2 -yl }amino -4 -oxobutanoic acidQ27094503Q-27094503Q 27094503